EFAV - ETF AI Analysis
Top Page
iShares MSCI EAFE Min Vol Factor ETF (EFAV)
Rating:61Neutral
Price Target:―
Positive Factors
Strong Year-To-Date Performance
The ETF has delivered strong gains so far this year, showing solid recent momentum for investors.
Resilient Top Holdings
Most of the largest positions, including major energy, financial, and healthcare companies, have shown strong or steady performance, helping support the fund’s returns.
Broad International Diversification
The fund spreads its investments across many countries outside the U.S., with meaningful exposure to Japan, the UK, Switzerland, and several other markets, which helps reduce reliance on any single economy.
Negative Factors
Heavy Japan Exposure
A large portion of the portfolio is invested in Japan, which means the fund’s results are strongly tied to how that single market performs.
Mixed Short-Term Performance
While the fund has done well year-to-date, its recent three-month performance has been weak, suggesting some loss of near-term momentum.
Moderate Fee Level
The expense ratio is not especially high but also not the lowest available, so costs still slightly reduce the returns investors keep.
EFAV Historical Chart
AUM5.52B
RegionDeveloped Markets
Expense Ratio0.20%
Beta0.31
IssueriShares
Inception DateOct 18, 2011
Dividend Yield3.01%
Asset ClassEquity
Index TrackedMSCI EAFE Minimum Volatility (USD)
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume354,599
30 Day Avg. Volume497,512
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
102.74Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering264
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
EFAV Summary
EFAV is the iShares MSCI EAFE Min Vol Factor ETF, which follows the MSCI EAFE Minimum Volatility Index. It invests in stocks from developed countries outside North America, such as Japan, the UK, and Europe, and aims to smooth out big market swings by focusing on companies with more stable share prices. Well-known holdings include Shell and Novartis. An investor might choose EFAV to add international diversification with a tilt toward lower-volatility stocks, seeking steadier long-term growth. A key risk is that it can still lose value and will rise and fall with global stock markets.
How much will it cost me?The iShares MSCI EAFE Min Vol Factor ETF (EFAV) has an expense ratio of 0.20%, which means you’ll pay $2 per year for every $1,000 invested. This is lower than the average for actively managed funds because EFAV is passively managed, tracking an index that focuses on minimizing volatility in developed markets outside North America.
What would affect this ETF?The EFAV ETF could benefit from stable economic growth in developed markets outside North America, particularly in sectors like financials, consumer defensive, and healthcare, which are well-represented in its portfolio. However, it may face challenges from rising interest rates, which could impact financial stocks, or geopolitical tensions in Europe and Asia that might affect market stability. Regulatory changes in these regions or shifts in global trade policies could also influence the ETF's performance.
EFAV Top 10 Holdings
EFAV is powered by a mix of steady financials and defensive global giants, with Singapore’s DBS and OCBC rising nicely and acting as key engines for the fund. European energy names like Shell, ENI, and TotalEnergies are also pulling their weight, giving the ETF a solid boost from the oil and gas patch. On the defensive side, Takeda and Novartis are holding up well, while Iberdrola and Secom look more mixed, occasionally losing steam. Overall, it’s a diversified, developed-markets ex‑U.S. play with no single sector dominating the story.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| DBS Group Holdings | 1.54% | $84.19M | S$223.51B | 60.04% | 78 Outperform | |
| Takeda Pharmaceutical Co | 1.51% | $82.47M | ¥9.18T | 19.85% | 66 Neutral | |
| Shell (UK) | 1.48% | $80.64M | £197.02B | 30.81% | 73 Outperform | |
| Iberdrola | 1.47% | $80.09M | €131.17B | 26.02% | 67 Neutral | |
| ― | 1.46% | $79.67M | ― | ― | ― | |
| Secom Co | 1.45% | $78.97M | ¥2.84T | 9.14% | 73 Outperform | |
| Novartis AG | 1.42% | $77.68M | CHF237.20B | 24.62% | 80 Outperform | |
| OCBC | 1.39% | $75.74M | S$145.03B | 91.43% | 71 Outperform | |
| ENI S.p.A. | 1.39% | $75.74M | €67.49B | 57.77% | 63 Neutral | |
| TotalEnergies SE | 1.37% | $74.70M | €169.87B | 42.48% | 78 Outperform |
EFAV Technical Analysis
Positive
―
Price Trends
92.03
Positive
90.57
Positive
88.97
Positive
Market Momentum
0.68
Positive
61.13
Neutral
67.79
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For EFAV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 94.01, equal to the 50-day MA of 92.03, and equal to the 200-day MA of 88.97, indicating a bullish trend. The MACD of 0.68 indicates Positive momentum. The RSI at 61.13 is Neutral, neither overbought nor oversold. The STOCH value of 67.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for EFAV.
EFAV Peer Comparison
Comparison Results
Performance Comparison
EFAV
iShares MSCI EAFE Min Vol Factor ETF
94.78
11.67
14.04%
DBEF
Xtrackers MSCI EAFE Hedged Equity ETF
―
―
―
BBIN
JPMorgan BetaBuilders International Equity ETF
―
―
―
HFXI
IQ 50 Percent Hedged FTSE International ETF
―
―
―
IHDG
WisdomTree International Hedged Quality Dividend Growth Fund
―
―
―
DDWM
WisdomTree Dynamic Currency Hedged International Equity Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents